Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial
| Image |  |
|---|---|
| Description | scientific article published on 14 February 2013 |
| Author/s |
author: Alexander Dobrovic |
| Publication date | February 14, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |